Actxa Showcases AI-Driven BGEM technology at TechInnovation 2025
Updated: Sep 7
Singapore, 23 October 2025 - Actxa is excited to participate in TechInnovation 2025, Asia’s premier platform for innovation and business transformation, organised by IPI Singapore, where we will showcase BGEM, our AI-driven, non-invasive blood glucose evaluation technology that advances the frontier of preventive health innovation.
BGEM® leverages AI to provide non-invasive glucose insights, helping individuals build greater awareness of their glucose patterns and better understand how everyday factors such as diet, activity and lifestyle may influence their wellbeing. These insights can support more informed health choices and long-term wellness. The technology reflects Actxa’s commitment to developing science-based solutions that make preventive health more accessible and relevant to everyday life.
Learn how Actxa’s AI-driven BGEM technology is shaping the future of preventive health.
Speaker Session
Topic: BGEM: AI for diabetic risk screening and control
Speaker: Dr. Du Yao, Head of Research and Development, Actxa
Date and Time: 30 Oct, Thursday at 3.30pm
Event Details
Date: 29 – 31 October 2025
Location: Sands Expo & Convention Centre, Level 3, Heliconia Ballroom
Stand: K02
Visit our stand to learn more about BGEM and connect with our team to explore how Actxa is shaping the future of preventive health through innovation.
Keen to speak with our team and explore collaboration opportunities? Secure your meeting slot https://forms.office.com/r/qhTpjtSQed
